CD8A-binding fibronectin type III domains | Patent Number 11299534

US 11299534 B2
Application Number16821064
Publication NumberUS 20210032312 A1
Pendency2 years, 26 days
Filled DateMar 17, 2020
Priority Date-
Publication DateFeb 4, 2021
Expiration DateMar 16, 2040
Inventor/ApplicantsManuel Sepulveda
Rebecca Hawkins
Steven Jacobs
ExaminesHADDAD, MAHER M
Art Unit1644
Technology Center1600
Assignments
Janssen Biotech Inc.
Current
Janssen Biotech Inc.Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.